Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 4
1 (50.0%)A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Phase 4
Not yet recruiting
- Conditions
- Edema Due to Heart Failure or Cirrhosis
- Interventions
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- CMP Development, LLC
- Target Recruit Count
- 96
- Registration Number
- NCT06021860
Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)
Phase 1
Completed
- Conditions
- Drug Drug Interaction
- Interventions
- First Posted Date
- 2019-04-10
- Last Posted Date
- 2023-05-01
- Lead Sponsor
- CMP Development, LLC
- Target Recruit Count
- 28
- Registration Number
- NCT03909529
- Locations
- 🇮🇳
ClinSync Clinical Research Pvt. Ltd., Hyderabad,, Telangana, India
News
No news found